Shanghai Junshi Biosciences (01877, 688180) Announces November 2025 Monthly Return

Bulletin Express12-04

Shanghai Junshi Biosciences Co., Ltd. released its monthly return for the period ended 30 November 2025. The total registered capital remained RMB 1,026,689,871, which includes 260,295,700 H shares (listed on the Hong Kong Stock Exchange under stock code 01877) and 766,394,171 A shares (listed on the STAR Market of the Shanghai Stock Exchange under stock code 688180). No changes were recorded in the number of issued H shares or A shares during the reporting period.

According to the disclosure, the H Share Option Incentive Scheme reported 13,210,000 share options outstanding at the start and end of November 2025, with no adjustments. Under the A Share Option Incentive Scheme, 450,000 share options were canceled during the month, reducing the outstanding total from 25,150,000 to 24,700,000. There were no share issuances, treasury share movements, warrants, or convertible securities during this period.

As stated in the filing, all relevant procedures, including those required by Hong Kong and mainland regulatory authorities, were completed in compliance with the respective rules and regulations. The company remains in full compliance with applicable listing and disclosure requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1138520658?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-04 16:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1138520658","market":"us","top_or_hot":-1,"title":"Shanghai Junshi Biosciences (01877, 688180) Announces November 2025 Monthly Return","media":"Bulletin Express","content":"<p>Shanghai Junshi Biosciences Co., Ltd. released its monthly return for the period ended 30 November 2025. The total registered capital remained RMB 1,026,689,871, which includes 260,295,700 H shares (listed on the Hong Kong Stock Exchange under stock code 01877) and 766,394,171 A shares (listed on the STAR Market of the Shanghai Stock Exchange under stock code 688180). No changes were recorded in the number of issued H shares or A shares during the reporting period.</p>\n<p>According to the disclosure, the H Share Option Incentive Scheme reported 13,210,000 share options outstanding at the start and end of November 2025, with no adjustments. Under the A Share Option Incentive Scheme, 450,000 share options were canceled during the month, reducing the outstanding total from 25,150,000 to 24,700,000. There were no share issuances, treasury share movements, warrants, or convertible securities during this period.</p>\n<p>As stated in the filing, all relevant procedures, including those required by Hong Kong and mainland regulatory authorities, were completed in compliance with the respective rules and regulations. The company remains in full compliance with applicable listing and disclosure requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Junshi Biosciences (01877, 688180) Announces November 2025 Monthly Return</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Junshi Biosciences (01877, 688180) Announces November 2025 Monthly Return\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-04 16:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Junshi Biosciences Co., Ltd. released its monthly return for the period ended 30 November 2025. The total registered capital remained RMB 1,026,689,871, which includes 260,295,700 H shares (listed on the Hong Kong Stock Exchange under stock code 01877) and 766,394,171 A shares (listed on the STAR Market of the Shanghai Stock Exchange under stock code 688180). No changes were recorded in the number of issued H shares or A shares during the reporting period.</p>\n<p>According to the disclosure, the H Share Option Incentive Scheme reported 13,210,000 share options outstanding at the start and end of November 2025, with no adjustments. Under the A Share Option Incentive Scheme, 450,000 share options were canceled during the month, reducing the outstanding total from 25,150,000 to 24,700,000. There were no share issuances, treasury share movements, warrants, or convertible securities during this period.</p>\n<p>As stated in the filing, all relevant procedures, including those required by Hong Kong and mainland regulatory authorities, were completed in compliance with the respective rules and regulations. The company remains in full compliance with applicable listing and disclosure requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01877","symbol_name":"君实生物","start_time":0,"source_url":"","article_id":"1138520658","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1138520658","pubTimestamp":1764837872,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Junshi Biosciences Co., Ltd. released its monthly return for the period ended 30 November 2025. The total registered capital remained RMB 1,026,689,871, which includes 260,295,700 H shares...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01877":"君实生物"},"translate_title":"上海君实生物(01877, 688180)公布2025年11月月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01877":1},"content_text":"Shanghai Junshi Biosciences Co., Ltd. released its monthly return for the period ended 30 November 2025. The total registered capital remained RMB 1,026,689,871, which includes 260,295,700 H shares (listed on the Hong Kong Stock Exchange under stock code 01877) and 766,394,171 A shares (listed on the STAR Market of the Shanghai Stock Exchange under stock code 688180). No changes were recorded in the number of issued H shares or A shares during the reporting period.\nAccording to the disclosure, the H Share Option Incentive Scheme reported 13,210,000 share options outstanding at the start and end of November 2025, with no adjustments. Under the A Share Option Incentive Scheme, 450,000 share options were canceled during the month, reducing the outstanding total from 25,150,000 to 24,700,000. There were no share issuances, treasury share movements, warrants, or convertible securities during this period.\nAs stated in the filing, all relevant procedures, including those required by Hong Kong and mainland regulatory authorities, were completed in compliance with the respective rules and regulations. The company remains in full compliance with applicable listing and disclosure requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1138520658","isCrawlerRequest":true}